The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of sunitinib and gemcitabine in sarcomatoid and/or poor-risk patients with metastatic renal cell carcinoma.
 
Rana R. McKay
Research Funding - Bayer; Pfizer
Travel, Accommodations, Expenses - Prostate Cancer Foundation
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
 
Lillian Werner
No Relationships to Disclose
 
Michael B. Atkins
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Amgen; C-Cam; Genentech; GlaxoSmithKline; Lilly; Merck; Neostem; Novartis; Novartis; Pfizer; X4 Pharma
 
Kara M. Olivier
No Relationships to Disclose
 
Jiaxi Song
No Relationships to Disclose
 
Sabina Signoretti
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Verastem
 
David F. McDermott
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Merck; Pfizer
Research Funding - Prometheus
 
M Dror Michaelson
Employment - Jounce Therapeutics (I)
Consulting or Advisory Role - Astellas Pharma; Medivation; Millennium; Novartis
Research Funding - Argos Therapeutics (Inst); Eisai (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); TRACON Pharma (Inst)